CVS Health Corporation (CVS) Stock Overview
Explore CVS Health Corporation’s financial performance, market position, analyst ratings, and future outlook.
CVS Health Corporation (CVS)
Key Financials
Key Financials
Market Cap
125.1B
P/E Ratio
42.18
EPS (TTM)
$2.28
ROE
0.04%
CVS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CVS Health Corporation (CVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 67.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.80.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 42.18 and a market capitalization of 125.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.